Phase 4 N=400 Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings
Diabetes Mellitus, Type 1 · Type 1 Diabetes
Primary: Time-in-serious Hypoglycemia — 3.6; 3.4; 2.4; 3.8 percentage of time — p=0.43
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=52 Impact of E-cigarette Nicotine Concentration on Compensation
Smoking Cessation
Primary: Total Inhaled Volume — 416.5; 490.3 mL
Phase 3 N=178 A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
Uremic Pruritus
Primary: Change From Baseline in the Mean NRS Score at Week 4 — -2.06; -1.09 points — p=<0.001
N/A N=151 DermAI to Evaluate Human Factor of Testing
Contact Dermatitis
Primary: Classification of Test Site Region Reaction — 1247; 163; 1126; 284 Skin Patch Interpretations
N/A N=4 A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
Liver Cirrhosis
Primary: Area Under the Concentration Time Curve of Caffeine, Omeprazole and Metoprolol in Plasma Over the Time Interval From 0 to 24 Hours (AUC0-24) — 20600; 1520; 287…
N/A N=106 PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband
Rotator Cuff Tears · Rotator Cuff Injuries
Primary: Assessment of Performance by Analyzing Soft Tissue to Bone Healing in the Shoulder (Rotator Cuff) — 105; 1 Participants
N/A N=19,853,610 Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data
SARS-CoV-2 · COVID-19 Vaccines
Primary: Number of Participants COVID-19 Diagnosis — 210902 Participants
Phase 2 N=46 Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
Multiple Myeloma
Primary: Number of Participants With Stringent Complete Response (sCR) — 17 Participants
N/A N=10 Children's Mercy Teens With Type 1 Diabetes Will Participate in an Online Peer Support Group.
Type 1 Diabetes
Primary: Discord User Metrics — 12.5 instances
Phase 4 N=180 A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
Psoriasis
Primary: Percentage of Participants Achieving Dermatology Life Quality Index (DLQI) Score of 0 or 1 at Week 16 — 33.3; 6.7; 32.7; 6.1 Percentage of Participants — p=0.0001
N/A N=22 Cochlear Promontory Stimulation for Treatment of Tinnitus
Tinnitus
Primary: Change in Short Term Relief of Tinnitus as Measured by the Tinnitus Handicap Inventory — -31 score on a scale
Phase 4 N=70 iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children
Feeding Behavior · Feeding Disorder of Infancy or Early Childhood
Primary: Participants Who Transitioned to Oral Feeding — 23; 24 Participants
Phase 4 N=19 Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair
Pain
Primary: Patient Satisfaction With Pain Management After Surgery — 4; 4; 2.5; 5 score on a scale
N/A N=30 Comparison of Non-invasive and Invasive Blood Pressure Monitors
Blood Pressure · Surgery · Intensive Care Unit
Primary: Comparison of Diastolic Blood Pressure — 0.90 mmHg
N/A N=67 Biatain Silicone Sacral for Pressure Injury Prevention in Hospital-admitted Patients at Risk
Pressure Injury Prevention
Primary: Number of Adverse Events — 0 Adverse events